Valuing EQ-5D using Time Trade-Off in France

Brooks, R.: EuroQoL: the current state of play. Health Policy 1, 53–72 (1996)

Torrance, G.W., Boyle, M.H., Horwood, S.P.: Application of multi-attribute theory to measure social preferences for health states. Oper. Res. 6, 1043–1069 (1982)

Ware, J.E., Sherbourne, C.D.: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 6, 473–483 (1992)

Le Galès, C., Buron, C., Costet, N., et al.: Développement d’un index d’états de santé pondéré par les utilités en population française: le health utilities index. Econ. Prev. 150, 71–87 (2001)

Collège des Économistes de la Santé: Guide méthodologique pour l’évaluation économique des stratégies de santé. Recommandations méthodologiques. Paris (2003)

Haute Autorité de Santé: L’évaluation économique à la Haute Autorité de Santé Principes et méthodes. Paris (2010)

Adam, P., Herzlich, C.: Sociologie de la maladie et de la médecine. Armand Colin (2007)

Johnson, J.A., Ohinmaa, A., Murti, B., et al.: Comparison of Finnish and U.S.-based visual analog scale valuations of the EQ-5D measure. Med. Decis. Making 20, 281–289 (2000)

Johnson, J.A., Luo, N., Shaw, J., et al.: Valuations of EQ-5D health states: are the United States and United Kingdom different? Med. Care 43, 221–228 (2005)

Lamers, L.M., McDonnell, J., Stalmeier, P., et al.: The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. Health Econ. 15, 1121–1132 (2006)

Golicki, D., Jakubczyk, M., Niewada, M., et al.: Valuations of EQ-5D health states in Poland: first TTO-based social value set in Central and Eastern Europe. Value Health 13, 289–297 (2010)

Dolan, P.: Modeling valuations for EuroQol health states. Med. Care 11, 1095–1108 (1997)

Macran, S., Kind, P.: Valuing EQ-5D health states using a modified MVH protocol: preliminary results. In: Badia, X., Herdman, M., Roset, M. (eds.) Proceedings of the 16th Plenary Meeting of the EuroQol Group, pp. 205–240. Institut de Salut Publica de Catalunya (2000)

Tsuchiya, A., Ikeda, S., Ikegami, N., et al.: Estimating an EQ-5D population value-set: the case of Japan. Health Econ. 4, 341–353 (2002)

Parkin, D., Devlin, N., Sharma, P.: A deathless and VAS-free EQ-5D self-completion valuation questionnaire. In: Stavem, K. (ed.) Proceedings of the 22nd Plenary Meeting of the EuroQol Group, Oslo, pp. 170–189 (2005)

Szende, A., Oppe, M., Devlin, N.: EQ-5D value sets. Inventory, comparative review and user guide. Springer, Dordrecht (2007)

Lamers, L.M.: The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value-sets. Med. Care 3, 238–244 (2007)

Shaw, J.W., Johnson, J.A., Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 3, 203–220 (2005)

Chuang, L.H., Kind, P.: The effect of health state selection on the valuation of EQ-5D. Med. Decis. Making 31, 186–194 (2010)

O’Brien, B.J., Drummond, M.F.: Statistical versus quantitative significance in the socioeconomic evaluation of medicines. Pharmacoeconomics 5, 389–398 (1994)

Devlin, N.J., Hansen, P., Kind, P., et al.: Logical inconsistencies in survey respondents’ health state valuations—a methodological challenge for estimating social tariffs. Health Econ. 7, 529–544 (2003)